Skip to main content

Find Clinical Trials

Home
Conditions
Recurrent HER2-Negative Breast Carcinoma

Clinical trial condition

Recurrent HER2-Negative Breast Carcinoma

Explore clinical trials studying Recurrent HER2-Negative Breast Carcinoma. Study availability and eligibility vary by location and protocol.

1 public trial 1 recruiting study

Refine in advanced search Browse all conditions

Recurrent HER2-Negative Breast Carcinoma trial results

Recruiting

Personalized Neo-Antigen Peptide Vaccine for the Treatment of Stage IIIC-IV Melanoma, Hormone Receptor Positive HER2 Negative Metastatic Refractory Breast Cancer or Stage III-IV Non-Small Cell Lung Cancer

NCT05098210

Conditions: Anatomic Stage IV Breast Cancer AJCC v8, Bronchial Neoplasms, Carcinoma, Bronchogenic, +46 more
Locations: Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States

View Trial Details